Clinical Trials in Tennessee

Showing 17301-17320 of 20,239 trials

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

NCT00899457

RATIONALE: Studying samples of blood, urine, sputum, mouth cells, and bronchial tissue from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors learn more about the development of cancer. PURPOSE: This laboratory study is looking for molecular markers in predicting lung cancer development using tissue samples from healthy participants.

Healthy, no Evidence of DiseaseLung Cancer

Vanderbilt-Ingram Cancer Center37 participantsStarted Apr 2008

Nashville, Tennessee, United States • Nashville, Tennessee, United States • Nashville, Tennessee, United States

COMPLETEDPhase 229 miles

Dose Range Finding Study of Fedovapagon in Men With Nocturia

NCT01656239

The purpose of this study is to determine the dose level(s) of fedovapagon which result in a decrease in the mean nocturnal void frequency.

Nocturia

Vantia Ltd358 participantsStarted Aug 2012

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +53 more locations

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

Dose Range Finding Study of Fedovapagon in Men With Nocturia

Find Trials by Condition in Tennessee

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Dapagliflozin DPPIV Inhibitor add-on Study

AST-120 Used to Treat Mild Hepatic Encephalopathy

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Effects of School Gardens on Children's Diet, Nutritional Knowledge, Etc.

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors